$3.15
+0.06 (+1.78%)
Open$3.14
Previous Close$3.09
Day High$3.56
Day Low$3.08
52W High$116.38
52W Low$1.92
Volume—
Avg Volume44.3K
Market Cap12.00M
P/E Ratio—
EPS$-98.35
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 462.8K | 474.7K | 442.2K |
| Net Income | -17,156 | -18,549 | -17,491 |
| Profit Margin | -3.7% | -3.9% | -4.0% |
| EBITDA | -38,868 | -39,496 | -31,996 |
| Free Cash Flow | -11,585 | -14,526 | -17,935 |
| Rev Growth | +1.4% | -0.9% | -6.2% |
| Debt/Equity | 0.29 | 0.36 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |